Orikines’s Website
Barcelona, ES · Founded 2022 · 18 employees on LinkedIn · 2 known investors
Find your way into Orikines’s Website
868 people in our graph share verified history with the Orikines’s Website team — schools, employers, funds. One of them is your warm intro.
Nina Kapurunlockedknows Ariadna Montero · together at UW Foster School of Business (overlapped)
×2knows the team · via Universitat Pompeu Fabra
knows the team · via The Rockefeller University
×2knows the team · via University of Buenos Aires
×4knows the team · via UW Foster School of Business
×2knows the team · via Universitat Autònoma de Barcelona
Orikine Bio develops engineered cytokines called Foldikines™ to reprogram immune responses for treating autoimmune and inflammatory diseases. The platform uses bi-specific cytokines designed to target specific immune cells with precision while minimizing off-target toxicities.
Founders & leadership
Orikines’s Website was founded in 2022 by Ariadna Montero, Alejo Chorny, Prof. Luis Serrano, and Dr. Javier Delgado.
AM
Ariadna MonteroinScientific Founder, Head of Innovation Management & Corp. Comm.Ariadna Montero holds a PhD in Biomedicine and an Executive MBA, with experience leading digital R&D initiatives in pharmaceutical drug design and product development. She is Scientific Founder and Head of Innovation Management & Corporate Communications at Orikine Bio.
AC
Alejo ChornyinCo-founder & Former-CEOAlejo Chorny co-founded Orikine Bio and served as CEO, building the company's pipeline around engineered cytokines for immune modulation; he previously held roles as operating partner at AdBio Partners and in business development and external innovation at BIAL Pharmaceuticals, with over 20 years of experience across academia, biotech, pharma, and venture capital.
PL
Prof. Luis SerranoScientific Founder, Advisor
DJ
Dr. Javier DelgadoScientific Founder, Advisor
CP
Christian PangratzinCEO & Board DirectorChristian Pangratz held senior leadership roles at multiple biotechnology and pharmaceutical companies including Nektar Therapeutics, Pfizer, Bayer, and Vectura Group, and served on boards of companies operating in pharmaceuticals and diagnostics across Switzerland, China, and Europe. He brings expertise in product management, business development, corporate strategy, and respiratory and immunological therapeutic areas.
Board
LE
Larry EdwardsChairman of the Board
Investors · 2
Frequently asked questions
- What does Orikines’s Website do?
- Orikine Bio develops engineered cytokines called Foldikines™ to reprogram immune responses for treating autoimmune and inflammatory diseases. The platform uses bi-specific cytokines designed to target specific immune cells with precision while minimizing off-target toxicities.
- Who founded Orikines’s Website?
- Orikines’s Website was founded by Ariadna Montero, Alejo Chorny, Prof. Luis Serrano, Dr. Javier Delgado in 2022.
- Who are Orikines’s Website's investors?
- Orikines’s Website's investors include AdBio partners, Asabys Partners.
- Where is Orikines’s Website headquartered?
- Orikines’s Website is headquartered in Barcelona, ES.